Non-invasive Prenatal Testing (NIPT) Driven by the Adoption of Next Generation Sequencing (NGS) Techniques for Screening is Driving Market Growth
Prenatal genetic tests are predominantly used to test disorders such as aneuploidies in chromosomes 21, 18, 13 and carrier screens. They are gaining momentum in EU due to enhanced assay outcomes through non-invasive methodologies using next generation sequencing (NGS) techniques, increasing number of women choosing to undergo pregnancy at an advanced maternal age (over 35 years) and considerable popularity through social media and e-commerce channels. High level of merger and acquisition activity apart from numerous collaborations with regional clinical labs has supported the participants in marketing their products across the European region.
Moreover, companies are also exploring new avenues to market their product by strategically tying up with IVF clinics, physicians, genetic counsellors and OBGYNs. Partnership with big data companies is anticipated to be the next big leap in the prenatal genetic testing market, thereby providing interpretation of vast volumes of data to increase specificity, sensitivity, and cost of tests. The key business model emerging across the market is the collaboration of key participants with regional private clinical labs as well as public centres and organizations such as NHS to increase the market coverage in Europe.
Research Scope The key objectives of this growth insights study are to track the transformations in the prenatal genetic test market landscape in Europe for 2016-2021. The study aims at identifying growth opportunities across the market and suggesting most profitable business models to market players.
Furthermore, the study provides an in-depth revenue and market analysis of 4 key segments within the prenatal landscape: NIPT, carrier screening for cystic fibrosis, invasive tests, and miscarriage tests. The study highlights industry challenges, growth drivers, restraints, competitive developments, key mergers and acquisitions (MandAs), and investment opportunities. Key trends across the market with respect to physician and patient attitudes toward prenatal genetic screening and its probable impact on growth are analyzed. Additionally, top growth opportunities, profiles of game-changing companies, disruptive technologies and innovative business models, along with strategic recommendations are included.
Key Issues Addressed Which are the most promising segments in the EU prenatal genetic testing market? Where is the most interest in terms of funding and innovation? What are the most favorable business models across the prenatal testing market in Europe? How are companies coping with the market drawbacks and needs? What are some of the most disruptive products in this market? Who are the key players in the market? What are the gaps in the market that encourage penetration and provide opportunities to new entrants?
Our reports have been used by over 10K customers, including:
KEY FINDINGS Text Analytics Market in Europe is expected to exhibit a substantial growth over the forecast period of 2018-2026 by growing at a CAGR of 19.80%. Monetizing of social media analytics, the emergence of multilingual text analytics to break the language barrier, growing social media and smartphone users and the...
KEY FINDINGS Legalization of cannabis for medical purposes has given a huge boost to the cannabis testing market. By the end of the forecast period of 2018-2026, the Europe cannabis testing market is predicted to exhibit a CAGR of 10.50%. MARKET INSIGHTS The market segments include cannabis testing...
KEY FINDINGS The CAGR for the European electrical steel market is expected to witness a CAGR of 5.86% over the forecast period of 2019-2027. Germany dominates the European market, and the total revenue of the European market is expected to reach $xx million by 2027. MARKET INSIGHTS The electrical...
KEY FINDINGS The expected CAGR of the European ground support equipment market is 10.05% over the forecast period of 2019-2027. The European ground support equipment market will continue to escalate in terms of revenue which is expected to reach up to $xx billion by 2027. MARKET INSIGHTS The German...
KEY FINDINGS For the forecast period of 2019-2027, the market for smart homes in the European region is expected to have a CAGR of 14.71%. The shift towards sustainable living is a major influencing factor for the growth of the smart homes market. MARKET INSIGHTS The constantly improving standard...
KEY FINDINGS The CAGR for the European Healthcare analytics market is poised to grow at 27.03% between the forecast period of 2019-2027. The European healthcare system is facing similar challenges as the rest of the world, which includes controlling costs, managing population health and chronic diseases. MARKET...
